[Recurrence-preventive (remission preserving) therapy of chronic inflammatory bowel diseases].
Kruis
W
W
Innere Abteilung des Evangelischen Krankenhauses Kalk, Köln.
Pohl
C
C
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002908:Chronic Disease; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D055502:Secondary Prevention; D012460:Sulfasalazine / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000963:Antimetabolites; D007166:Immunosuppressive Agents; D012460:Sulfasalazine; D001379:Azathioprine; D011241:Prednisone
Rezidiv-verhütende (remissionserhaltende) Therapie bei chronisch-entzündlichen Darmerkrankungen.